High prevalence of α-1-antitrypsin heterozygosity in children with chronic liver disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 44, Issue 1, 2007, Pages 99-103

  Campbell, Kathleen M ^a,b   Arya, Gajra ^a,b   Ryckman, Frederick C ^a,b   Alonso, Maria ^a,b   Tiao, Greg ^a,b   Balistreri, William F ^a,b   Bezerra, Jorge A ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

1 antitrypsin; Biliary atresia; Genetic modifier; Liver transplantation

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ALLELE; ARTICLE; BILE DUCT ATRESIA; CHI SQUARE TEST; CHILD; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HETEROZYGOSITY; HUMAN; LIVER GRAFT; MEDICAL RECORD REVIEW; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REFERENCE DATABASE; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

ALPHA 1-ANTITRYPSIN; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; HETEROZYGOTE; HUMANS; INFANT; LIVER DISEASES; POLYMORPHISM, GENETIC; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 33846036488     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000243434.54958.21     Document Type: Article

References (33)

1. Rudnick DA, Perlmutter DH. Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease. Hepatology 2005;42:514-21.
2. Graziadei IW, Joseph JJ, Wiesner RH, et al. Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency. Hepatology 1998;28:1058-63.
3. Hodges JR, Millward-Sadler GH, Barbatis C, et al. Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N Engl J Med 1981;304:557-60.
4. Tabesh A, Bonatti H, Machicao V, et al. Patients transplanted for non alcoholic steatohepatitis have a higher prevalence of heterozygous alpha 1-antitrypsin phenotype. Hepatology 2004.
5. Regev A, Guaqueta C, Torres M. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study. Hepatology 2004;43:S30-5.
6. Pratt DS, Trainer TD, Krawitt EL. Heterozygous alpha1-antitrypsin deficiency and chronic hepatitis C. Clin Gastroenterol Hepatol 2005;3:xxix.
7. Hug G, Chuck G, Slemmer TM, et al. Pi Ecincinnati: a new alpha 1-antitrypsin allele in three Negro families. Hum Genet 1980;54:361-4.
8. de Serres FJ. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest 2002;122:1818-29.
9. Vecchio FM, Fabiano A, Orsini G, et al. Alpha-1-antitrypsin MZ phenotype and cryptogenic chronic liver disease in adults. Digestion 1983;27:100-4.
10. Morin T, Martin JP, Feldmann G, et al. Heterozygous alpha 1-antitrypsin deficiency and cirrhosis in adults, a fortuitous association. Lancet 1975;1:250-1.
11. Hashemi M, Alavian SM, Ghavami S. High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran. Hepatol Res 2005;33:292-7.
12. Pott G, Schneider M, van Husen N, et al. alpha 1-Antitrypsin phenotypes in patients with chronic liver diseases. Z Gastroenterol 1983;21:318-23.
13. Lima LC, Matte U, Leistner S, et al. Molecular analysis of the Pi*Z allele in patients with liver disease. Am J Med Genet 2001;104:287-90.
14. Okayama H, Brantly M, Holmes M, et al. Characterization of the molecular basis of the alpha 1-antitrypsin F allele. Am J Hum Genet 1991;48:1154-8.
15. Cook L, Burdon JG, Brenton S, et al. Kinetic characterisation of alpha-1-antitrypsin F as an inhibitor of human neutrophil elastase. Pathology 1996;28:242-7.
16. Beckman G, Stjernberg NL, Eklund A. Is the PiF allele of alpha 1-antitrypsin associated with pulmonary disease? Clin Genet 1984;25:491-5.
17. Cockcroft DW, Tennent RK, Horne SL. Pulmonary emphysema associated with the FZ alpha 1-antitrypsin phenotype. Can Med Assoc J 1981;124:737-42.
18. Chardot C, Carton M, Spire-Bendelac N, et al. Epidemiology of biliary atresia in France: a national study. J Hepatol 1999;31:1006-13.
19. Mack CL, Sokol RJ. Unraveling the pathogenesis and etiology of biliary atresia. Pediatr Res 2005;57:87R-94R.
20. Vockley J, Rinaldo P, Bennett MJ, et al. Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways. Mol Genet Metab 2000;71:10-8.
21. Kohsaka T, Yuan ZR, Guo SX, et al. The significance of human jagged 1 mutations detected in severe cases of extrahepatic biliary atresia. Hepatology 2002;36:904-12.
22. Geier A, Reugels M, Weiskirchen R, et al. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C. Liver Int 2004;24:285-94.
23. Henrion-Caude A, Flamant C, Roussey M, et al. Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism. Hepatology 2002;36:913-7.
24. Salvatore F, Scudiero O, Castaldo G. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes. Am J Med Genet 2002;111:88-95.
25. Lafuente MJ, Casterad X, Laso N, et al. Pi*S and Pi*Z alpha 1 antitrypsin polymorphism and the risk for asbestosis in occupational exposure to asbestos. Toxicol Lett 2002;136:9-17.
26. Breit SN, Wakefield D, Robinson JP, et al. The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders. Clin Immunol Immunopathol 1985;35:363-80.
27. Camussi G, Tetta C, Bussolino F, et al. Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases. J Exp Med 1988;168:1293-306.
28. Joslin G, Griffin GL, August AM, et al. The serpin-enzyme complex (SEC) receptor mediates the neutrophil chemotactic effect of alpha-1 antitrypsin-elastase complexes and amyloid-beta peptide. J Clin Invest 1992;90:1150-4.
29. Libert C, Van Molle W, Brouckaert P, et al. alpha1-Antitrypsin inhibits the lethal response to TNF in mice. J Immunol 1996;157:5126-9.
30. Van Molle W, Libert C, Fiers W, et al. Alpha 1-acid glycoprotein and alpha 1-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice. J Immunol 1997;159:3555-64.
31. Hayes VM, Gardiner-Garden M. Are polymorphic markers within the alpha-1-antitrypsin gene associated with risk of human immunodeficiency virus disease? J Infect Dis 2003;188:1205-8.
32. Shapiro L, Pott GB, Ralston AH. Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1. FASEB J 2001;15:115-22.
33. Petrache I, Fijalkowska I, Zhen L, et al. A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema. Am J Respir Crit Care Med 2006;173:1222-8.